Market Closed -
Nasdaq
21:00:00 10/05/2024 BST
|
5-day change
|
1st Jan Change
|
1.21
USD
|
-4.72%
|
|
-6.20%
|
+24.10%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
46.02
|
10.63
|
21.11
|
26.74
|
-
|
-
|
Enterprise Value (EV)
1 |
46.02
|
10.63
|
21.11
|
26.74
|
26.74
|
26.74
|
P/E ratio
|
-3.48
x
|
-0.94
x
|
-1.05
x
|
-1.85
x
|
-3.01
x
|
-6.37
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
39
x
|
8.81
x
|
19.7
x
|
4.33
x
|
2
x
|
0.89
x
|
EV / Revenue
|
39
x
|
8.81
x
|
19.7
x
|
4.33
x
|
2
x
|
0.89
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-5.59
x
|
-
|
-
|
-2.23
x
|
-3.34
x
|
-3.82
x
|
FCF Yield
|
-17.9%
|
-
|
-
|
-44.9%
|
-29.9%
|
-26.2%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
11,800
|
11,814
|
21,650
|
22,099
|
-
|
-
|
Reference price
2 |
3.900
|
0.9000
|
0.9750
|
1.210
|
1.210
|
1.210
|
Announcement Date
|
24/03/22
|
30/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1.18
|
1.206
|
1.072
|
6.18
|
13.35
|
30.03
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-8.337
|
-11.6
|
-14.51
|
-13.79
|
-13.9
|
-11.35
|
Operating Margin
|
-
|
-706.69%
|
-961.7%
|
-1,353.44%
|
-223.17%
|
-104.11%
|
-37.78%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-11.39
|
-14.24
|
-14.41
|
-12.16
|
-8.646
|
Net income
1 |
-6.915
|
-
|
-11.39
|
-14.25
|
-14.41
|
-12.16
|
-8.646
|
Net margin
|
-
|
-
|
-944.62%
|
-1,329.06%
|
-233.08%
|
-91.13%
|
-28.79%
|
EPS
2 |
-0.8000
|
-1.120
|
-0.9600
|
-0.9300
|
-0.6525
|
-0.4025
|
-0.1900
|
Free Cash Flow
1 |
-
|
-8.238
|
-
|
-
|
-12
|
-8
|
-7
|
FCF margin
|
-
|
-698.29%
|
-
|
-
|
-194.16%
|
-59.94%
|
-23.31%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/02/21
|
24/03/22
|
30/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
0.2543
|
0.3214
|
0.3031
|
0.3475
|
0.2342
|
0.294
|
0.3205
|
0.2444
|
0.2131
|
0.2711
|
1.833
|
1.73
|
1.937
|
3.218
|
3.029
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-2.358
|
-2.883
|
-2.66
|
-3.057
|
-3
|
-
|
-2.936
|
-4.081
|
-4.45
|
-3.463
|
-3.122
|
-3.76
|
-3.686
|
-
|
-
|
Operating Margin
|
-927.04%
|
-896.91%
|
-877.56%
|
-879.87%
|
-1,280.89%
|
-
|
-916.03%
|
-1,670.18%
|
-2,087.9%
|
-1,277.07%
|
-170.32%
|
-217.38%
|
-190.29%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-2.634
|
-2.983
|
-2.888
|
-
|
-2.894
|
-3.997
|
-4.406
|
-3.6
|
-3.189
|
-3.826
|
-4.129
|
-
|
-
|
Net income
1 |
-
|
-
|
-2.634
|
-2.983
|
-2.894
|
-
|
-2.894
|
-3.997
|
-4.41
|
-3.6
|
-3.189
|
-3.826
|
-4.129
|
-
|
-
|
Net margin
|
-
|
-
|
-869.02%
|
-858.47%
|
-1,235.57%
|
-
|
-902.78%
|
-1,635.66%
|
-2,069.57%
|
-1,327.55%
|
-173.96%
|
-221.24%
|
-213.16%
|
-
|
-
|
EPS
2 |
-
|
-
|
-0.2200
|
-0.2500
|
-0.2400
|
-0.2500
|
-0.2200
|
-0.2600
|
-0.1900
|
-0.1700
|
-0.1625
|
-0.1700
|
-0.1550
|
-0.1800
|
-0.1400
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
24/03/22
|
11/05/22
|
10/08/22
|
10/11/22
|
30/03/23
|
11/05/23
|
10/08/23
|
14/11/23
|
28/03/24
|
09/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-8.24
|
-
|
-
|
-12
|
-8
|
-7
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
0.31
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
26.01%
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/02/21
|
24/03/22
|
30/03/23
|
28/03/24
|
-
|
-
|
-
|
Last Close Price
1.21
USD Average target price
10
USD Spread / Average Target +726.45% Consensus |